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We are interested in synthesizing a potential PAM-agonist 
with minimal intrinsic effects by using isooxazoline 
characteristic structure. The synthesis of isooxazoline through 
1,3-dipolar cycloaddition with the purpose of being used as a 
potential PAM  agonist with minimal intrinsic effects. The 
product from phase two is an electron rich dipole which allows 
its highest occupied molecular orbital (HOMO) to interact 
with the lowest unoccupied molecular orbital (LUMO) of a 
dipolarphile. This phase formed the ring which is 
characteristic of isooxazoline core motif. Analysis from figure 
A shows a peak at 148.1 m/z which shows the protonated 
version of the oxime of interest that has a molecular ion of 
147.17. Correspondingly, 77.0 m/z is similar to that of a 
deprotonated benzene ring which has a molecular ion of 78.11 
Analysis of MS from figure B showed that the compound of 
interest have been created. Phase two created the dipole, 
nitrile oxide, to be able to interact with the dipolarphile, 
acrylamide, through 1,3-dipolar cycloaddition. Analysis of TLC 
(not shown) showed unconvincing data that the core motif has 
been created. But, through the use of MS, there seems to be 
more convincing data. Figure D shows the benzene peak at 
76.0 m/z. There is a styrene peak at 102.0 m/z which could be 
shown from the breakdown of the molecule. The peak at 129.0 
m/z is the other half from the styrene which includes the 
carboxamide, isoxazole, and a methyl that has a total 
molecular ion of 128.13. Future research requires synthesizing 
the top and pendent motif for which it can be attached to the 
core to fully create the proposed isooxazoline structure. 
Looking further down the line, the proposed structure can be 
tested as a PAM-agonist compound hopefully with minimal 
intrinsic effects to test against Alzheimer’s disease.
Discussion
1) Discovery of the Potent and Selective M1 PAM-Agonist N‐[(3R,4S)‐3-
Hydroxytetrahydro‐2H‐pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-
yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy 
and Cholinergic Side Effects
2) Design and Synthesis of γ- and δ‐Lactam M1 Positive Allosteric Modulators 
(PAMs): Convulsion and Cholinergic Toxicity of an M1‐Selective PAM with 
Weak Agonist Activity
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The progression of Alzheimer’s disease (AD) is correlated to 
the degenerative activation of muscarinic acetylcholine 
receptors (mAChR) located in the brain. They are a family of 
five G-protein coupled receptors, (M1-M5), linked to have 
functions within the central and peripheral nervous system.1
More specifically, activation of an M1 receptor with positive 
allosteric modulators (PAM), have shown to bind to the 
allosteric pocket and slow the degenerative process of AD with 
minimal intrinsic effects.2 Structural motifs of potent PAM 
activity and weak agonism proposed a synthesis of an 
isooxazoline compound, incorporating a 1,3-dipolar 
cycloaddition. The core motif of the proposed isooxazoline 
structure has been created and further synthesis of the 
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Figure A is the chromatogram of phase 1 in representative of the 
molecule of interest, cinnamaldehyde oxime, with the 
breakdown of the molecule on figure B. Figure B represents the  
shows multiple peaks at that 13.187 minutes, Figure A. There is 
a peak at 148.1 m/z and two large peaks at 130.0 m/z and 77.0 
m/z. 
Figure C and E represents analysis for phase 2 for synthesizing the 
isooxazoline core motif. Figure D shows the mass spectroscopy 
data of the core motif breakdown at 11.641 minutes as seen on 
figure C. There are peaks at 129.o m/z, 102.o m/z, and 76.0 m/z 
that represents different parts of the molecule when being broken 
down. 
The creation of the proposed 
isooxazoline core motif occurs in 
two phases. The first phase 
synthesized cinnamaldehyde oxime   
by adding 20 mmol of 
cinnamaldehyde into a solution of 5 
mL of H2O, 5 mL ethanol, and 10 mL of ice. Added to this 
solution was 40 mmol of a 50% aqueous solution of NaOH and 
stirred for 18 hours at room 
temperature. The oxime was 
then extracted from the 
organic phase while the aqueous phase was acidified to pH 5 
from HCl and was extracted once more. 
The second phase formed the ring through 1,3-dipolar 
cycloaddition which is the core motif. This was synthesized by 
adding oxime with 2.79 mL of triethylamine and 1.864 g of 
cyanuric chloride in an ice bath for 15 minutes to create the 
nitrile. The oxide was then removed from the ice bath and left 
under constant agitation for 30 minutes with 20 mL of diethyl 
ether and extracted by gravity filtration. The oxide and 1.421 g of 
acrylamide was added and stirred for 24 hours. Mass 
spectrometer (MS) was used to analyze both phases while  thin 
layer chromatography (TLC) and nuclear magnetic resonance 
(NMR) was used on the second phase. 
